Showing 1661-1670 of 2050 results for "".
- Alimera Completes Recruitment for Its NEW DAY Study Evaluating Iluvien for DMEhttps://modernod.com/news/alimera-completes-recruitment-for-its-landmark-new-day-study/2481633/Alimera Sciences announced that it has completed enrollment for the company’s NEW DAY clinical trial, a randomized, controlled, multicenter study designed to generate prospective data for Iluvien (fluocinolone acetonide intravitreal implant, 0.19mg) as a baseline therapy in p
- Dr. Louis R. Pasquale Winner of the Glaucoma Foundation's 2023 Robert Ritch Awardhttps://modernod.com/news/dr-louis-r-pasquale-winner-of-the-glaucoma-foundations-2023-robert-ritch-award/2481629/Louis R. Pasquale, MD, FARVO, has been named the 2023 recipient of The Glaucoma Foundation’s (TGF) Robert Ritch Award for Innovation and Excellence in Glaucoma. Created in 2008, the award recognizes the contributions of individuals who have played a significant and unique role in promoting
- Novel Imaging Technology Reveals Role of Immune Cells in Early Diabetic Cataract Developmenthttps://modernod.com/news/novel-imaging-technology-reveals-role-of-immune-cells-in-early-diabetic-cataract-development-1/2481623/Novel findings from researchers at the Brigham and Women's Hospital and Harvard Medical School, in collaboration with the Health Campus Göttingen in Germany, contradict previous notions about sugar's role in the onset of diabetic cataracts, according to a University Medical Center G&
- Euclid and Visionary Optics Announce Interactive Specialty Lens Forums in Cities Across the UShttps://modernod.com/news/euclid-and-visionary-optics-announce-interactive-specialty-lens-forums-in-cities-across-the-us/2481620/Euclid Vision is joining forces with Visionary Optics to host multiple specialty contact lens dinner discussions in cities around the US. The program,
- Nanoscope Therapeutics Presents Key Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of RP at ARVOhttps://modernod.com/news/nanoscope-therapeutics-presents-key-results-from-phase-2b-restore-trial-of-mco-010-for-the-treatment-of-rp-at-arvo/2481583/Nanoscope Therapeutics announced the presentation of key data from its phase 2b multicenter, randomized, double-masked, sham-controlled RESTORE clinical trial (NCT04945772) of MCO-010 at the ARV
- EssilorLuxottica Unveils 4-Year Clinical Trial Results of its Essilor Stellest Lens athttps://modernod.com/news/essilorluxottica-unveils-4-year-clinical-trial-results-of-its-essilor-stellest-lens-at-arvo-at/2481572/EssilorLuxottica presented the 4-year clinical trial results of its Essilor Stellest lens for myopia control at the 2023 ARVO annual meeting in New Orleans. The findings show that Essilor Stellest lenses continue to exhibit strong efficacy in slowing myopia progression and axial ey
- Lenstar Myopia Now Includes New AMMC Framework by Prof. Dr. Hakan Kaymakhttps://modernod.com/news/lenstar-myopia-now-includes-new-ammc-framework-by-prof-dr-hakan-kaymak/2481558/Haag-Streit has announced that the Lenstar Myopia now includes the new AMMC framework by Prof. Dr. Hakan Kaymak. The new Age-Matched Myopia Control (AMMC) framework is designed to provide diagnostic support based on the eye’s axial growth for myopia m
- Visus Therapeutics Announces Positive Topline Clinical Data from Phase 3 Trial of Brimochol PF for the Treatment of Presbyopiahttps://modernod.com/news/visus-therapeutics-announces-positive-topline-clinical-data-from-phase-3-trial-of-brimochol-pf-for-the-treatment-of-presbyopia/2481543/Visus Therapeutics reported positive topline results from its phase 3 pivotal BRIO-I trial. BRIO-I met the prespecified primary study endpoints agreed upon with the FDA and EMA/MHRA, demonstrating contribution of elements for the once-daily, fixed-dose combination, Brimochol PF, over both ac
- Lumata Health and Prevent Blindness Announce Partnership Aimed at Delivering More Resources to Americans with Vision Losshttps://modernod.com/news/lumata-health-and-prevent-blindness-announce-partnership-aimed-at-delivering-more-resources-to-americans-with-vision-loss/2481522/Lumata Health announced a partnership with Prevent Blindness which will focus on various initiatives to address barriers to care for patients, with a strong focus on mental health resources to start. “Our care coordinators are in frequent contact with pati
- Nidek Announces the Winners of the 3rd Annual Images of the Year Awardhttps://modernod.com/news/nidek-announces-the-winners-of-the-3rd-annual-images-of-the-year-award/2481521/Nidek has announced the winners of the 3rd Annual Images of the Year Award. While continuing the theme “invisible to visible,” this year’s contest highlighted how multiple imaging techniques of the Mirante Scanning Laser Ophthalmoscope (NIDEK) helps retina specialists visua